This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Thursday, May 15, 2014
Medicare Backs Down On Denying Treatment For Hepatitis Patient
Medicare Backs Down On Denying Treatment For Hepatitis Patient
Walter Bianco, an Arizona man denied access to new drugs to cure his
hepatitis C infection, will get the costly medications after all.
After NPR and Kaiser Health News reported his plight on Monday, federal Medicare
officials said they would investigate. Bianco's appeal of an earlier
denial had been rejected by WellCare, a private insurer that contracts
with the federal program to provide drug coverage.
Late Tuesday, Bianco's doctor got word that the earlier denials had been reversed.
Update 6:08 PM: Sean Cavanaugh, deputy administrator of the ,
told NPR: "Widely-accepted treatment guidelines for Hepatitis C have
recently been updated, and it is our understanding that the Part D plan
decided to overturn its denial of a particular Hepatitis C treatment
based on guidance that was not available at the time of the initial
decision."
But it's not clear whether Bianco's case does indeed set a precedent.....
No comments:
Post a Comment